Healx, an AI-powered, patient-inspired, biotech company, is seeking rare disease therapeutic opportunities from academic, patient groups or (early-stage) biotechs. Healx, along with their partners, aim to quickly turn research into treatments that benefit the rare disease community, and Healx will manage the costs of clinical trials and regulatory submissions for all selected opportunities (subject to final deal terms).
Approaches of Interest
Spinout Company
Technology
Research Project
Spinout Company
Technology
Research Project
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.